Lingual Ischemia from Prolonged Insertion of a Fastrach Laryngeal Mask Airway by Gerstein, Neal S. et al.
Volume XII, no. 1  :  February 2011  124  Western Journal of Emergency Medicine
Case report
      Lingual Ischemia from Prolonged Insertion        
of a Fastrach Laryngeal Mask Airway
Neal S. Gerstein, MD
Darren Braude, MD
James S. Harding, MD
Angela Douglas, MD
  University of New Mexico, Albuquerque, NM
Supervising Section Editor: Sean Henderson, MD
Submission history: Submitted July 13, 2010; Revision received November 12, 2010; Accepted November 15, 2010
Reprints available through open access at http://scholarship.org/uc/uciem_westjem
CASE REPORT
A 75-year-old woman (71 kg, 165 cm) was brought to a 
small, rural, emergency department (ED) with a two-day 
history of headache and confusion. Computerized tomography 
of the head demonstrated an acute intracerebral hemorrhage 
without signs of midline shift. One hour into her ED course 
the patient had a brief generalized tonic-clonic seizure 
followed by a second seizure 20 minutes later. The patient 
then developed a prolonged postictal phase and appeared 
unable to protect her airway, prompting endotracheal 
intubation. After three unsuccessful intubation attempts by 
direct laryngoscopy (DL) performed by a single ED physician, 
a size 5 FastrachTM Intubating Laryngeal Mask Airway® 
(FT-LMA) [Laryngeal Mask Company, Jersey, UK] was 
successfully inserted as a rescue airway device. It is unknown 
why a FT-LMA was selected, what volume of air was used to 
inflate the FT-LMA cuff, or why intubation via the FT-LMA 
was not attempted. The patient was placed on a ventilator, 
appropriate medical management was instituted, and she was 
transported to our facility for definitive neurosurgical care.   
The patient arrived in the intensive care unit at our facility 
approximately five hours after placement of the FT-LMA. The 
anesthesia team was consulted for endotracheal intubation 
and removal of the FT-LMA. An initial oral exam revealed 
edema and marked purple-black discoloration of the tongue. 
Fiberoptic bronchoscope (FOB) exam through the FT-LMA 
demonstrated marked edema of all glottic structures. After 
unsuccessful attempts to intubate the patient with FOB-
assistance through the FT-LMA, a bedside tracheostomy was 
performed by the surgical service. The FT-LMA was then 
removed and the oropharnyx inspected, revealing the entire 
length of tongue (from tip to base) to be swollen, markedly 
purple-black in coloration, and free of lacerations. Pictures 
taken two days later with the patient awake and following 
commands demonstrated residual discoloration of the tongue 
(Figure 1). The patient denied any sensory deficits to the 
tongue, dysarthria, dysphagia, or stridor. The patient did not 
experience any necrosis or sloughing of her lingual mucosal 
surfaces and did not appear to have any lasting sequela 
from the prolonged FT-LMA insertion. She was ultimately 
discharged home in good condition.
DISCUSSION
A number of different extraglottic devices are available 
for use in the ED. The FT-LMA is an intubating laryngeal 
airway intended to provide both ventilation and the consistent 
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ability to pass an endotracheal tube (ETT) blindly into the 
trachea. It has been in use for over 12 years with an overall 
low complication rate.1 Reported complications include: 
esophageal intubation, esophageal perforation, sore throat, 
dysphagia, dental damage and aspiration.2-7 Because the 
FT-LMA is used primarily to facilitate intubation in the 
operating room and then removed, there is little information 
on complications from prolonged insertion. The FT-LMA is 
more likely to be left in place when used in the ED and 
emergency medical service settings either because providers 
are not trained to intubate through it (used strictly as a rescue 
device), have less experience and therefore less success at 
intubation, and/or because of recommendations not to attempt 
removal in these settings.1
Kihara et al5 showed that the pharyngolaryngeal morbidity 
of sore throat and mouth was more common with the FT-LMA 
compared to the ClassicTM laryngeal mask airway (C-LMA) 
following anesthesia lasting one to two hours. However, the 
degree of morbidity of their complications was significantly less 
than our current case. It is possible that our patient’s lingual 
ischemia was exacerbated by the three intubation attempts or by 
trauma secondary to a seizure activity; however, an 
oropharyngeal exam revealed no evidence of oropharyngeal 
injury or lacerations. Moreover, she did not have history of 
coagulopathy or conditions predisposing her to lingual ischemia 
(i.e. vascular disease, diabetes). The dearth of traumatic 
evidence in combination with Keller et al8 pharyngeal pressure 
data point to the FT-LMA as the likely culprit. 
Using strain gauge microchip sensors attached to a size 5 
FT-LMA, Keller et al8 demonstrated that the FT-LMA 
generates pharyngeal mucosal pressures that exceed estimated 
mucosal capillary perfusion pressures at the manufacturer’s 
recommended intracuff volumes. They suggest that the device 
be left in situ the shortest possible time to reduce the chance 
of pharyngeal mucosal ischemia and injury.8A literature search 
revealed no case reports of clinically significant injuries 
related to prolonged FT-LMA insertion times. There are two 
cases of significant lingual edema in an infant and an adult 
after the use of a C-LMA.9-10 However, we are reporting the 
first serious complication due to the prolonged FT-LMA use in 
an elderly female stroke patient in which significant lingual 
ischemia resulted after an insertion time of less than five 
hours. 
Keller et al8 demonstrated that the FT-LMA provides a 
more effective seal than the C-LMA, but pharyngeal mucosal 
pressures are significantly higher and always exceed capillary 
perfusion pressure when typical cuff volumes are used. The 
major difference between the FT-LMA and other laryngeal 
masks (i.e. the C- LMA, UniqueTM, ProSealTM [P-LMA]) is its 
rigid metal airway tube. This airway tube is pressed against 
the anterior cervical vertebrae in the distal hypopharynx 
generating an area of maximal pharyngeal pressure.8
In a more recent cadaveric study, Ulrich-Pur et al11 used 
microchip sensors to examine mucosal pressure exerted by the 
cuffs of various airway devices including the FT-LMA, 
C-LMA and the P-LMA. They too found that the FT-LMA 
exerted the greatest pharyngeal pressure at all recommended 
cuff volumes and concluded “cuff pressures do not suggest a 
clinically relevant danger, because the investigated devices…
are not intended for prolonged use.”11 We would suggest the 
ultimate duration of use for a particular device may be 
unpredictably prolonged; hence, an understanding of its 
hazards is in order.
Other extraglottic airway devices have also been 
implicated as the cause of various oropharyngeal trauma 
issues. The literature is replete with oropharyngeal nerve 
(hypoglossal, lingual, recurrent laryngeal) injuries associated 
with the use of the C-LMA.12-18 Two prior reports describe 
significant lingual edema with the use of the C-LMA. In the 
first of these, an oversized C-LMA (use of size 2.5 when 2 is 
recommended) was placed in a 10.6 kg one-year-old for a 
five-hour case.9 The other case involved a correctly sized 
C-LMA placed in an adult that led to marked lingual edema 
and cyanosis after a 90-minute procedure .10 Both cases were 
exemplary for noticeable tongue protrusion out of the mouth 
after initial inflation of the C-LMA’s cuff. The authors 
postulate tongue protrusion may indicate a potential size 
mismatch between the device and the patient’s oropharynx, 
which may contribute to venous or arterial obstruction.
The P-LMA has also been implicated as causing injury to the 
lingual, hypoglossal and recurrent laryngeal nerves.19-21 A recent 
case involved the uncuffed i-Gel (Intersurgical, Wokingham, 
Berkshire, UK) in which a patient had an atraumatic device 
placement for a two-hour case and awoke with a sore and 
partially numb tongue that also had decreased taste; these 
symptoms persisted for three weeks.22 Though our patient did not 
have any sensory deficits, it is likely that a similar traumatic 
mechanism due to prolonged placement or malposition may have 
led to either impaired tongue arterial perfusion or venous 
drainage resulting in a compromised airway.
Various factors should be employed to insure that cuff 
pressure is minimized when using the FT-LMA – whether for 
brief or prolonged use. Clinicians should insure that cuff 
volumes are kept to the manufacturers’ recommendations and 
that cuff pressure is monitored if the FT-LMA is used beyond 
a brief placement for intubation. If it is necessary to use the 
FT-LMA as the primary airway device, the cuff volumes 
should be minimized. For example, an adequate seal may be 
achieved with far less than the recommended maximum of 40 
ml for the size 5 FT-LMA, especially if a patient is being 
vigorously resuscitated with the predictable resultant airway 
edema. Additionally, multiple authors and the manufacturer all 
suggest that the device be removed immediately after 
successful intubation.1,8,11,23 If FT-LMA removal is not possible 
but an ETT is able to be placed via the FT-LMA, it is 
imperative that the FT-LMA cuff be deflated once 
endotracheal intubation is confirmed. 
Finally, two additional issues need to be addressed. 
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Firstly, it was not documented as to why the initial attempts at 
DL were unsuccessful. The cause of the difficult DL would 
possibly have helped elucidate the putative factors generating 
her lingual ischemia. Secondly, it is unclear why a size 5 
FT-LMA was selected for the case patient. By size 
characteristics, a size 4 FT-LMA would have been more 
appropriate in a 71-kg 165-cm-tall woman. Though the size 5 
FT-LMA allowed for adequate ventilation, the inability to 
perform FOB-assisted intubation indicates it was not seated 
appropriately in the laryngeal inlet and likely contributed to 
the lingual ischemia. In the authors’ experience, when using 
the FT-LMA, the inability to adequately visualize the glottis 
via a FOB with minimal device manipulations is a strong 
indicator that the incorrect size FT-LMA has been chosen. In 
this case, the size 5 FT-LMA was likely too large and led to 
possible lingual injury.
While the FT-LMA remains an outstanding extraglottic 
airway device, this case demonstrates that caution is necessary 
when leaving the FT-LMA in place for periods of several 
hours or more. Suggested techniques to limit harm include 
removing the device as soon as feasible, using minimum 
cuff volumes, and deflating the cuff entirely if intubation is 
achieved but the device cannot be safely removed. 
RECOMMENDATIONS TO MINIMIZE RISK OF 
OROPHARYNGEAL, LARYNGEAL, AND LINGUAL 
INJURY
Appropriate training
Before using the FT-LMA, the clinician should fully read 
the manufacturer’s instruction guide (http://www.lmana.com/
docs/IFU(US)-Fastrach.pdf).23 Ideally, clinicians should gain 
experience in placement, intubation and removal in an elective 
setting in patients with non-difficult airways. Also, experience 
with the FT-LMA should also be obtained by using the device 
in a simulator/mannequin setting. 
Appropriate size selection
  Size 3 - 30-50 kg
  Size 4 - 50-70 kg
  Size 5 - 70-100 kg
It is important to note that the weight ranges have some 
overlap and clinical judgment may lead one to place a certain 
size FT-LMA in a patient that falls outside the respective 
devices’ weight range (i.e. placing a size 4 in a 90 kg obese 
short-statured patient).
Minimize cuff pressure / volume
If the FT-LMA is used without an ETT, insure no more 
than the maximum volume of air is used in the cuff (20cc - 
size 3; 30cc - size 4; 40cc - size 5). The recommended 
maximum cuff pressure is 60 cm H2O if the device is only 
being used as a conduit to intubation; if it is being left in situ, 
a pressure of 20-30 cm H2O is recommended.23 Moreover, it is 
very common to have an adequate seal and appropriate 
ventilatory parameters with cuff volumes that are as low as 
half the recommended inflation volume.
If one is unable to directly measure cuff pressure, an 
alternative to insuring minimal cuff pressures is to pressurize 
the breathing circuit and observe airway pressures while 
listening for a cuff leak. One can then minimize the cuff 
volume while insuring the cuff leak is achieved at 20 cm H2O 
of airway pressure. 
If an ETT is placed via the FT-LMA, but the device is 
unable to be removed, leave the FT-LMA cuff fully deflated 
and have it removed at the earliest possible point.
Additionally, if the FT-LMA is left in situ, the head and 
neck of the patient should be kept midline and in the neutral 
position in order to minimize device pressure.
Minimize duration of time device remains in-situ
Because of the above discussed issues with its prolonged 
use, the FT-LMA should be removed as soon as possible, 
regardless of whether it has been used as a conduit for 
intubation or as a stand-alone device. There are no formal 
guidelines or published recommendations on the maximum 
duration the FT-LMA can safely be left in situ. 
Intubation via the FT-LMA
Blind intubation and assisted-methods (i.e. FOB) have 
high (>90%) first attempt success rates with the FT-LMA.
Blind intubation recommendations:
Gerstein et al.  Lingual Edema from Fastrach LMA
Figure 2. FastrachTM Intubating Laryngeal Mask Airway® Western Journal of Emergency Medicine  127  Volume XII, no. 1  :  February 2011
1.  Insure ventilation is optimal via FT-LMA initially (insures 
glottis and device aperture aligned)
2.  Consider adjunctive drugs (low muscle relaxant, opioids)
3.  Raise device in vertical / sagittal plane
4.  Use well-lubricated (water based) reinforced ETT or 
reverse-oriented standard ETT (to minimize angle of exit 
from FT-LMA aperture) 
Indirect / adjunctive intubation recommendations:
1.  FOB guidance is the author’s preferred technique because 
of the likely minimal airway trauma generated and the 
assurance of confirming the definitive tracheal placement 
of the ETT. Two recommendations from our significant 
experience with the FOB include: a) insure the liberal 
application of a water-based lubricant to the FOB and the 
airway tube of the FT-LMA and b) insure that the FOB is 
advanced at least halfway to the carina to insure the FOB 
does not slip out during ETT advancement. 
2.  Airway exchange catheter can be inserted through 
FT-LMA and tracheal placement confirmed with 
capnography followed by ETT insertion.
3.  Gum elastic bougie was used in emergency airway 
situations when a FOB was unavailable. Once the FT-
LMA is in place, the bougie is inserted through the airway 
tube, tracheal rings can be detected by feel, and an ETT 
can be advanced over the bougie.
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